Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial (Q35713057)

9 August 2017

Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial (English)

1 reference

9 August 2017

0 references

1 reference

10

Marilyn A Huestis

1 reference

9 August 2017

7

Robert R Conley

1 reference

9 August 2017

Douglas L Boggs

1

1 reference

9 August 2017

Deanna L Kelly

2

1 reference

9 August 2017

Robert P McMahon

3

1 reference

9 August 2017

James M Gold

4

1 reference

9 August 2017

David A Gorelick

5

1 reference

9 August 2017

Jared Linthicum

6

1 reference

9 August 2017

Fang Liu

8

1 reference

9 August 2017

James Waltz

9

1 reference

9 August 2017

Robert W Buchanan

11

1 reference

9 August 2017

language of work or name

English

0 references

publication date

3 December 2011

1 reference

9 August 2017

Schizophrenia Research

1 reference

9 August 2017

134

1 reference

9 August 2017

2-3

1 reference

9 August 2017

207-210

1 reference

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Evaluation of CB1 receptor knockout mice in the Morris water maze

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Inhibitory effects of SR141716A on G-protein activation in rat brain

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Insensitivity to future consequences following damage to human prefrontal cortex

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Accuracy in parameter estimation for ANCOVA and ANOVA contrasts: sample size planning via narrow confidence intervals

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

By carrot or by stick: cognitive reinforcement learning in parkinsonism

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Cannabinoid inhibition improves memory in food-storing birds, but with a cost.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Temporal dynamics of brain activation during a working memory task.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3268840

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22137462

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22137462

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.SCHRES.2011.11.009

1 reference

9 August 2017

1 reference

9 August 2017

1 reference